SCHEMBL6833375

SCHEMBL6833375

COc1ccc(C(=O)Nc2c(Cl)cccc2Cl)c2c1OCCO2

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.57
ALDH1A1 P00352 1/20 0.57
LMNA P02545 1/20 0.57
HSD17B10 Q99714 1/20 0.57
MAPT P10636 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
PDE4D Q08499 7/20 0.48
PDE4A P27815 6/20 0.47
PDE4B Q07343 6/20 0.47
PDE4C Q08493 6/20 0.47
POLB P06746 1/20 0.47
NPC1 O15118 2/20 0.46
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833145 0.88 PDE4D (0.65) KDM4EALDH1A1LMNAHSD17B10PDE4D
SCHEMBL6833314 0.83 PDE4D (0.62) PDE4DPDE4APDE4BPDE4C
SCHEMBL6836687 0.83 PDE4D (0.62) PDE4DPDE4APDE4BPDE4C
SCHEMBL8296866 0.78 ALDH1A1 (0.69) KDM4EALDH1A1LMNAHSD17B10MAPT
SCHEMBL6837337 0.78 KDM4E (0.57) KDM4EALDH1A1LMNAHSD17B10PDE4D
SCHEMBL6836500 0.77 ALDH1A1 (0.56) KDM4EALDH1A1LMNAHSD17B10MAPT
SCHEMBL5723285 0.75 PDE4D (0.61) PDE4DPDE4APDE4BPDE4C
SCHEMBL11271758 0.75 KDM4E (0.73) KDM4EALDH1A1LMNAHSD17B10MAPT
SCHEMBL4467144 0.75 KDM4E (0.73) KDM4EALDH1A1LMNAHSD17B10MAPT
SCHEMBL6729531 0.73 ALDH1A1 (1.00) KDM4EALDH1A1LMNAHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed
EP-0943613-A1 OXYGENIC HETEROCYCLIC COMPOUNDS KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) 1999-09-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 KDM4E 3975/4885ALDH1A1 323/4885LMNA 1848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.